Peculiarities of Temperament and Character of Patients with Comorbid Psychiatric Pathology and Combined Dependence on Psychostimulants and Other Psychoactive Substances

Konstantin N. Poplevchenkov , Tatyana V. Agibalova , Oleg Zh. Buzik , Denis A. Mischenko

I.P. Pavlov Russian Medical Biological Herald ›› 2022, Vol. 30 ›› Issue (4) : 507 -518.

PDF (250KB)
I.P. Pavlov Russian Medical Biological Herald ›› 2022, Vol. 30 ›› Issue (4) :507 -518. DOI: 10.17816/PAVLOVJ105870
Original study
research-article

Peculiarities of Temperament and Character of Patients with Comorbid Psychiatric Pathology and Combined Dependence on Psychostimulants and Other Psychoactive Substances

Author information +
History +
PDF (250KB)

Abstract

INTRODUCTION: According to official statistics, there is an annual increase in the production and consumption of various psychostimulants, and as a result, an increase in the number of patients with addiction of psychostimulants. At the same time, there are no effective methods of treating such disorders within the framework of a modern personalized approach to therapy.

AIM: To study peculiarities of the temperament and character of patients with combined dependence on psychostimulants and other psychoactive substances (PASs) and with comorbid psychiatric pathology to increase the effectiveness of psychotherapeutic methods in personalized therapeutic approach.

MATERIALS AND METHODS: The study included 325 patients (ethnic Russian men and women aged from 18 to 50 years) with the diagnosis: ‘dependence on psychostimulants’ and ‘dependence on psychostimulants in combination with comorbid psychiatric pathology’, who signed the informed consent. R. Cloninger method of assessment of the temperament and character (Temperament and Character Inventory, TCI-125) was used.

RESULTS: Patients were divided to groups depending on PASs used by them and the existence of comorbid psychiatric pathology. Of temperament dimensions, the ‘novelty seeking’ predominated in all the groups (up to 15 points; р < 0.002) in comparison with ‘harm avoidance’ (up to 10 points; р < 0.112), ‘reward dependence’ (up to 9 points; р < 0.442) and ‘persistence’ (up to 3 points; р < 0.226). This combination of temperament dimensions corresponds to antisocial personality disorder. High ‘cooperativeness’ (17 points; p < 0.005) was observed in patients with a full course of rehabilitation and remissions up to 12 months. The maximal ‘self-transcendence’ (10 points; p < 0.02) corresponded to psychiatric pathology.

CONCLUSION: On the basis of the results obtained, personality profiles of patients were determined. Patients of the first profile with dependence only on psychostimulants with minimal ‘novelty seeking’ dimension of the temperament along with high ‘cooperativeness’ character trait were more communicative, adapted to the treatment and rehabilitation program, and had longer remission periods. Patients of the second profile with a combined dependence on psychostimulants and other PASs with maximal ‘novelty seeking’ dimension in the temperament along with minimal values on the character scales required the maximal effort of the specialists to keep them in the treatment and rehabilitation program. Patients of the third profile with dependence on psychostimulants and comorbid psychiatric pathology with maximal ‘novelty seeking’ dimension in the temperament together with maximal ‘self-transcendence’ were characterized by suspiciousness and required a special gradual establishment of psychotherapeutic contact to involve them in the treatment and rehabilitation process.

Keywords

psychostimulants / temperament / character / personalized profiles / dependence

Cite this article

Download citation ▾
Konstantin N. Poplevchenkov, Tatyana V. Agibalova, Oleg Zh. Buzik, Denis A. Mischenko. Peculiarities of Temperament and Character of Patients with Comorbid Psychiatric Pathology and Combined Dependence on Psychostimulants and Other Psychoactive Substances. I.P. Pavlov Russian Medical Biological Herald, 2022, 30(4): 507-518 DOI:10.17816/PAVLOVJ105870

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

World Drug Report 2021. [Internet]. Available at: https://www.unodc.org/res/wdr2021/field/WDR21_Booklet_4.pdf. Accessed: 2022 April 04.

[2]

World Drug Report 2021. Доступно по: https://www.unodc.org/res/wdr2021/field/WDR21_Booklet_4.pdf. Ссылка активна на 04 апреля 2022.

[3]

Koshkina EA, Bryun EA, Kirzhanova VV, et al. Monitoring of mental and behavioral disorders associated with the use of psychoactive substances in Moscow in 2017–2018. Narcology. 2020;19(4):22–34. (In Russ). doi: 10.25557/1682-8313.2020.04.22-34

[4]

Кошкина Е.А., Брюн Е.А., Киржанова В.В., и др. Мониторинг психических и поведенческих расстройств, связанных с употреблением психоактивных веществ в Москве в 2017–2018 годах // Наркология. 2020. Т. 19, № 4. С. 22–34. doi: 10.25557/1682-8313.2020.04.22-34

[5]

Hassan Z, Bosch OG, Singh D, et al. Novel Psychoactive Substances — Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs. Frontiers in Psychiatry. 2017;8:152. doi: 10.3389/fpsyt.2017.00152

[6]

Hassan Z., Bosch O.G., Singh D., et al. Novel Psychoactive Substances — Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs // Frontiers in Psychiatry. 2017. Vol. 8. P. 152. doi: 10.3389/fpsyt.2017.00152

[7]

Kibitov AO. Substance use disorders as ‘pharmacogenetic’ diseases. Voprosy Narkologii. 2017;(4–5):129–52. (In Russ).

[8]

Кибитов А.О. Болезни зависимости от психоактивных веществ как «фармакогенетические» заболевания // Вопросы наркологии. 2017. № 4–5. С. 129–152.

[9]

Pal’tsev MA. Personifitsirovannaya meditsina. Nauka v Rossii. 2011;(1):12–7. (In Russ).

[10]

Пальцев М.А. Персонифицированная медицина // Наука в России. 2011. № 1. С. 12–17.

[11]

Neznanov NG, Rukavishnikov GV, Kas'yanov ED, et al. Biopsychosocial model in psychiatry as an optimal paradigm for relevant biomedical research. V.M. Bekhterev Review of Psychiatry and Medical Psychology. 2020;(2):3–15. (In Russ). doi: 10.31363/2313-7053-2020-2-3-15

[12]

Незнанов Н.Г., Рукавишников Г.В., Касьянов Е.Д., и др. Био-психосоциальная модель в психиатрии как оптимальная парадигма для современных биомедицинских исследований // Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева. 2020. № 2. С. 3–15. doi: 10.31363/2313-7053-2020-2-3-15

[13]

Herrero MJ, Domingo–Salvany A, Torrens M, et al. Personality profile in young current regular users of cocaine. Substance Use & Misuse. 2008;43(10):1378–94. doi: 10.1080/10826080801922652

[14]

Herrero M.J., Domingo–Salvany A., Torrens M., et al. Personality profile in young current regular users of cocaine // Substance Use & Misuse. 2008. Vol. 43, № 10. P. 1378–1394. doi: 10.1080/10826080801922652

[15]

Quednow BB, Hulka LM, Preller KH, et al. Stable self-serving personality traits in recreational and dependent cocaine users. PLoS One. 2017;12(3):e0172853. doi: 10.1371/journal.pone.0172853

[16]

Quednow B.B., Hulka L.M., Preller K.H., et al. Stable self-serving personality traits in recreational and dependent cocaine users // PLoS One. 2017. Vol. 12, № 3. P. e0172853. doi: 10.1371/journal.pone.0172853

[17]

Enikolopov SN, Efremov AG. Issledovaniye psikhologicheskikh kharakteristik deviantnogo povedeniya s pomoshch’yu biosotsial’noy metodiki — struktura kharaktera i temperamenta (TCI-125) i metodiki vyyavleniya stepeni vyrazhennosti shizotipicheskikh chert (SPQ-74). Ezhegodnik Rossiyskogo Psikhologicheskogo Obshchestva. Psikhologiya v Sisteme Nauk (Mezhdistsiplinarnyye Issledovaniya). 2002;9(1):92. (In Russ).

[18]

Ениколопов С.Н., Ефремов А.Г. Исследование психологических характеристик девиантного поведения с помощью биосоциальной методики — структура характера и темперамента (TCI-125) и методики выявления степени выраженности шизотипических черт (SPQ-74) // Ежегодник российского психологического общества. Психология в системе наук (междисциплинарные исследования). 2002. Т. 9, № 1. С. 92.

[19]

Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Archives of General Psychiatry. 1993;50(12):975–90. doi: 10.1001/archpsyc.1993.01820240059008

[20]

Cloninger C.R., Svrakic D.M., Przybeck T.R. A psychobiological model of temperament and character // Archives of General Psychiatry. 1993. Vol. 50, № 12. P. 975–990. doi: 10.1001/archpsyc.1993.01820240059008

[21]

Cloninger СR, van Eerdewegh P, Goate A, et al. Anxiety proneness linked to epistatic loci in genome scan of human personality traits. American Journal of Medical Genetics. 1998;81(4):313–7. doi: 10.1002/(sici)1096-8628(19980710)81:4<313::aid-ajmg7>3.0.co;2-u

[22]

Cloninger С.R., van Eerdewegh P., Goate A., et al. Anxiety proneness linked to epistatic loci in genome scan of human personality traits // American Journal of Medical Genetics. 1998. Vol. 81, № 4. Р. 313–317. doi: 10.1002/(sici)1096-8628(19980710)81:4<313::aid-ajmg7>3.0.co;2-u

[23]

Garcia D, Lester N, Cloninger KM, et al. Temperament and Character Inventory (TCI). In: Zeigler–Hill V, Shackelford TK, editors. Encyclopedia of Personality and Individual Differences. Springer, Cham.; 2017. P. 1–3. doi: 10.1007/978-3-319-28099-8_91-1

[24]

Garcia D., Lester N., Cloninger K.M., et al. Temperament and Character Inventory (TCI). In: Zeigler–Hill V., Shackelford T.K., editors. Encyclopedia of Personality and Individual Differences. Springer, Cham.; 2017. P. 1–3. doi: 10.1007/978-3-319-28099-8_91-1

[25]

MacDonald DA, Holland D. Examination of the psychometric properties of the temperament and character inventory self- transcendence dimension. Personality and Individual Differences. 2002;32(6):1013–27. doi: 10.1016/s0191-8869(01)00107-6

[26]

MacDonald D.A., Holland D. Examination of the psychometric properties of the temperament and character inventory self-transcendence dimension // Personality and Individual Differences. 2002. Vol. 32. № 6. P. 1013–1027. doi: 10.1016/s0191-8869(01)00107-6

[27]

Rokhlina ML, Kozlov AA. Narkomanii. Meditsinskiye i sotsial’nyye posledstviya. Lecheniye. Moscow: Anakharsis; 2001. (In Russ).

[28]

Рохлина М.Л., Козлов А.А. Наркомании. Медицинские и социальные последствия. Лечение. М.: Анахарсис; 2001.

[29]

Fadeyeva EV, Grigor’yeva AA, Tsvetkova OV. Rezul’taty diagnostiki psikhologicheskikh osobennostey lichnosti, prediktorov zavisimogo povedeniya. Klinicheskaya i Meditsinskaya Psikhologiya: Issledovaniya, Obucheniye, Praktika. 2015;(2). Available at: http://www.medpsy.ru/climp/2015_2_8/article03.php. Accessed: 2022 April 04. (In Russ).

[30]

Фадеева Е.В., Григорьева А.А., Цветкова О.В. Результаты диагностики психологических особенностей личности, предикторов зависимого поведения // Клиническая и медицинская психология: исследования, обучение, практика. 2015. № 2 (8). Доступно по: http://www.medpsy.ru/climp/2015_2_8/article03.php. Ссылка активна на 04 апреля 2022.

[31]

Dyomina MV. O mekhanizmakh narusheniya soznaniya pri narkoticheskoy bolezni i podkhody ego korrektsii. Voprosy Narkologii. 2005;(1):13–20. (In Russ).

[32]

Дёмина М.В. О механизмах нарушения сознания при наркотической болезни и подходы его коррекции // Вопросы наркологии. 2005. № 1. С. 13–20.

[33]

Daneluzzo E, Stratta P, Rossi A. The contribution of temperament and character to schizotypy multidimensionality. Comprehensive Psychiatry. 2005;46(1):50–5. doi: 10.1016/j.comppsych.2004.07.010

[34]

Daneluzzo E., Stratta P., Rossi A. The contribution of temperament and character to schizotypy multidimensionality // Comprehensive Psychiatry. 2005. Vol. 46, № 1. Р. 50–55. doi: 10.1016/j.comppsych.2004.07.010

[35]

Svrakic DM, Cloninger CR. Pharmacotherapy and the Psycho- biological Model of Personality: Implications for DSM-5. Current Psycho-pharmacology. 2011;(2):122–36. doi: 10.2174/2211556011201020122

[36]

Svrakic D.M., Cloninger C.R. Pharmacotherapy and the psychobiological model of personality: implications for DSM-5 // Current Psychopharmacology. 2011. № 2. Р. 122–136. doi: 10.2174/2211556011201020122

RIGHTS & PERMISSIONS

Eco-Vector

PDF (250KB)

156

Accesses

0

Citation

Detail

Sections
Recommended

/